INSTALLED BUILDING PRODUCTS, INC.
IBP
$205.39
+1.66%
Installed Building Products, Inc. (IBP) is a leading installer of fiberglass, spray foam, and cellulose insulation for the U.S. residential new construction market, and also provides a diversified suite of complementary installation services including waterproofing, fire-stopping, garage doors, rain gutters, window blinds, shower doors, closet shelving, and mirrors across its Installation, Manufacturing, and Distribution segments. The company operates as a scaled, acquisition-driven consolidator in a highly fragmented installer market, with its national footprint, installer labor force of roughly 10,400 employees, and builder relationships giving it a distinct cost and service advantage over smaller regional competitors. The current investor narrative is dominated by a sharp cyclical downturn in single-family housing starts and affordability-driven demand softness, which has pushed revenue into year-over-year decline and the stock down roughly 25% over the past year. Debate centers on whether IBP's margin resilience, strong balance sheet, and M&A pipeline can offset volume pressure, and whether the QXO-TopBuild consolidation saga could reposition IBP as a relative safe-haven play in the installation space.…
IBP
INSTALLED BUILDING PRODUCTS, INC.
$205.39
Related headlines
Investment Opinion: Should I buy IBP Today?
Rating: Hold. IBP is a high-quality but cyclical installer caught in a housing downturn, and at $199.12 the stock offers only about +7.2% upside to the $213.46 average analyst target against a 'hold' consensus (2.71 mean rating) — a balanced-to-slightly-negative risk/reward that does not justify aggressive accumulation until housing volumes inflect.
Supporting evidence is mixed but leans cautious. The bull case rests on a 30% trailing-to-forward PE compression (26.58x to 18.48x), a 37.39% ROE, and Q1 2026 free cash flow of $85.7 million, all of which show the business remains profitable and cash-generative at the cycle trough. However, revenue is declining 3.55% YoY, gross margin has fallen to 30.55% from 32.67%, trailing FCF is only $63.1 million (a 0.9% yield), and the stock trades at 2.35x PS and 9.83x book — upper-middle of its historical range and well above 2022-2023 trough multiples. The 61% spread in analyst targets ($160-$257) underscores how uncertain the earnings trajectory is.
The biggest risks that could invalidate even a Hold are a further leg down in single-family starts, gross margin breaking below 30%, and forward EPS estimates being cut from $12.39. This Hold would upgrade to Buy if housing starts inflect and gross margin stabilizes above 33% with forward PE holding below 20x, or downgrade to Sell if revenue declines accelerate beyond -5% YoY or the stock breaks the $176.15 52-week low. On balance, the stock is fairly valued relative to its own history and slightly expensive relative to its current negative growth trajectory — not a compelling entry point, but not a broken business either.
Sign up to view all
IBP 12-Month Price Forecast
IBP is a profitable, cash-generative installer trading at a fair-to-slightly-rich valuation during a cyclical trough, with the market already discounting an earnings recovery via the 30% trailing-to-forward PE compression. The business quality is real — 37.39% ROE, 13.01% trailing operating margin, and $85.7 million of Q1 free cash flow — but revenue is contracting and margins are compressing, and the stock's -25.51% one-year decline with a 1.72 beta shows how much pain a housing downturn can inflict. Analyst sentiment is cautious ('hold', 2.71 mean, +7.2% average upside), and the wide $160-$257 target range reflects genuine uncertainty about the housing trajectory. I would upgrade to bullish if single-family starts inflect and gross margin stabilizes above 33%, and downgrade to bearish if revenue declines accelerate beyond -5% YoY or the $176.15 low breaks. Until then, a neutral stance with a bias toward waiting for confirmation is warranted.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on INSTALLED BUILDING PRODUCTS, INC.'s 12-month outlook, with a consensus price target around $212.86 and implied upside of +3.6% versus the current price.
Average Target
$212.86
0 analysts
Implied Upside
+3.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$160 - $257
Analyst target range
IBP is covered by 13 analysts with a consensus recommendation of "hold" (mean rating of 2.71 on a scale where lower is more bullish), reflecting a cautious stance amid housing cyclicality. The average target price is $213.46, implying roughly +7.2% upside from the current $199.12, a modest signal that the consensus sees the stock as fairly valued near current levels. The distribution skews neutral-to-bearish, with recent actions including JP Morgan maintaining Underweight (May 13, 2026), RBC Capital upgrading to Sector Perform from Underperform (May 8, 2026), and Goldman Sachs maintaining Buy, while DA Davidson, Truist, Stephens, Evercore, and Wells Fargo all sit at Neutral/Equal Weight/In Line. The target range spans $160.00 to $257.00, a wide 61% spread that signals high uncertainty: the high target of $257.00 (about +29% upside) likely assumes a housing recovery, multiple expansion toward the forward PE of 18.5x, and successful M&A deployment, while the low target of $160.00 (about -20% downside) prices in continued volume declines, margin compression, and a prolonged affordability-driven downturn. The wide dispersion and predominantly neutral ratings indicate limited conviction, and with consensus forward EPS of $12.39 against a $199.12 price, the market is already discounting a recovery; absent a clear housing inflection or positive estimate revisions, the risk/reward appears balanced to slightly negative.
Drowning in data?
Find the real signal!
Bulls vs Bears: IBP Investment Factors
The bear case currently carries stronger evidence: revenue is contracting (-3.55% YoY), margins are compressing (gross margin down 212 bps YoY), the stock is in a confirmed downtrend (-25.51% over one year, -38.64% relative strength), and the 26.58x trailing PE already discounts a recovery that has not begun. The bull case rests on forward-looking factors — 18.48x forward PE, a 37.39% ROE, strong Q1 cash flow of $85.7 million, and a possible safe-haven bid from the QXO-TopBuild consolidation — but these are anticipatory rather than confirmed. The single most important tension is whether U.S. single-family housing starts inflect before margin compression erodes the earnings base the forward multiple depends on; if starts recover, the 30% trailing-to-forward PE compression is justified and the stock is cheap, but if they stay depressed, estimates of $12.39 EPS will be cut and the valuation will look expensive. Until that resolution, the risk/reward is balanced to slightly negative, consistent with the 'hold' consensus and only +7.2% average target upside.
Bullish
- Forward PE compresses 30% on recovery: IBP trades at 26.58x trailing PE but only 18.48x forward PE, a roughly 30% compression that implies consensus EPS of $12.39 versus the current trailing run-rate. If that earnings recovery materializes, the stock is meaningfully cheaper than the headline multiple suggests.
- Still highly profitable at cycle trough: Despite a 3.55% revenue decline in Q1 2026, IBP generated $34.8 million of net income (5.27% net margin), $58.6 million of operating income, and a 37.39% ROE. A labor-intensive installer holding double-digit operating margins (13.01% trailing) through a housing downturn demonstrates real pricing power and cost discipline.
- Strong liquidity and cash generation: Q1 2026 produced $102.3 million of operating cash flow and $85.7 million of free cash flow against just $16.6 million of capex, while the current ratio stands at a healthy 3.03x with $474.3 million of cash. The company repaid $180.3 million of debt in the quarter, showing balance sheet flexibility even in a soft volume environment.
- Safe-haven angle in QXO-TopBuild saga: News coverage frames IBP as a potentially safer alternative to QXO's leveraged, integration-heavy bet on TopBuild. As a scaled consolidator with a national installer footprint and roughly 10,400 employees, IBP could attract capital rotating away from deal-risk exposure in the installation space.
Bearish
- Revenue now contracting year-over-year: Q1 2026 revenue of $660.5 million fell 3.55% versus $684.8 million a year earlier, extending a deceleration from $747.5 million in Q4 2025 and $778.2 million in Q3 2025. With single-family starts depressed, organic volume recovery depends on a housing inflection that has not appeared.
- Margins compressing on fixed-cost deleverage: Gross margin fell to 30.55% in Q1 2026 from 32.67% a year earlier, and operating margin contracted to 8.87% from 10.19%. The sequential erosion from Q4 2025's 34.98% gross margin shows that falling volumes are hitting profitability faster than costs can be cut.
- Valuation offers little cyclical cushion: At 26.58x trailing PE, 2.35x PS, 9.83x book, and a 3.99x PEG ratio, IBP sits in the middle-to-upper portion of its historical band, well above 2022-2023 trough multiples of 8-10x PE. The market is already pricing an earnings recovery, leaving limited downside protection if housing stays weak.
- Severe relative underperformance and downtrend: IBP is down 25.51% over one year and 25.55% YTD against the S&P 500's +13.13%, a relative strength gap of -38.64%. At $199.12 the stock sits at roughly 13.3% of its 52-week range with a max drawdown of -47.61%, a falling-knife technical profile.
IBP Technical Analysis
IBP is in a sustained, broad-based downtrend, with the stock down 25.51% over the past year and 25.55% year-to-date, badly lagging the S&P 500's +13.13% one-year return (relative strength of -38.64%). At a current price of $199.12, the stock sits at roughly 13.3% of its 52-week range of $176.15 to $349.00, meaning it is trading near the bottom of its annual band and has surrendered more than half its peak value, with a max drawdown of -47.61%. This positioning signals a falling-knife profile rather than a value opportunity, as the stock has repeatedly failed to hold rallies and remains far below any meaningful moving-average support. Recent momentum remains negative but is decelerating: the 1-month change of -1.81% and 3-month change of -12.45% are less severe than the 6-month decline of -34.19%, suggesting the pace of selling has moderated. The 1-month relative strength of -0.79% versus SPY's -1.02% indicates IBP is roughly in line with a weak tape rather than diverging sharply, while the most recent session's +0.50% gain to $199.12 and a short ratio of 3.37 days suggest some short-covering support near the $180-$190 zone. Key technical support sits at the 52-week low of $176.15, roughly 11.5% below the current price; a breakdown there would likely trigger momentum-driven selling toward new lows. Resistance is anchored at the 52-week high of $349.00, with intermediate resistance near the $230-$250 area where the stock repeatedly stalled in July and August. With a beta of 1.72, IBP is roughly 72% more volatile than the market, meaning position sizing should be materially smaller than a market-beta equivalent and stop-loss discipline is critical given the elevated downside capture in a housing-sensitive cyclical.
Beta
1.72
1.72x market volatility
Max Drawdown
-47.6%
Largest decline past year
52-Week Range
$176-$349
Price range past year
Annual Return
-24.3%
Cumulative gain past year
| Period | IBP Return | S&P 500 |
|---|---|---|
| 1m | +2.6% | -0.2% |
| 3m | -10.8% | +5.5% |
| 6m | -28.8% | +7.1% |
| 1y | -24.3% | +12.3% |
| ytd | -23.2% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBP Fundamental Analysis
IBP's revenue trajectory has turned negative: Q1 2026 revenue of $660.5 million declined 3.55% year-over-year versus $684.8 million in Q1 2025, extending a deceleration from Q4 2025's $747.5 million and Q3 2025's $778.2 million. The sequential and year-over-year softness reflects lower single-family housing starts and reduced installation volumes, with the Installation segment (roughly $609.8 million of reported segment value) and Insulation ($376.5 million) carrying the bulk of revenue while smaller lines like garage doors ($38.2 million), waterproofing ($38.3 million), and window blinds ($16.1 million) provide diversification but not enough scale to offset core volume pressure. The growth trend implies a cyclical trough rather than structural share loss, but until housing activity inflects, top-line recovery depends on acquisitions and price/mix rather than organic volume. Profitability remains solid but is compressing: Q1 2026 net income was $34.8 million with a net margin of 5.27%, down from $45.4 million and a 6.63% net margin in Q1 2025, while gross margin fell to 30.55% from 32.67% a year earlier and operating margin contracted to 8.87% from 10.19%. The trailing gross margin of 33.97% and operating margin of 13.01% remain respectable for a labor-intensive installer, and the company is still profitable with a 37.39% ROE, but the sequential erosion from Q4 2025's 34.98% gross margin and 14.56% operating margin shows fixed-cost deleverage as volumes fall. Balance sheet and cash flow are adequate but not fortress-like: debt-to-equity stands at 1.48x, the current ratio is a healthy 3.03x, and Q1 2026 generated $102.3 million of operating cash flow and $85.7 million of free cash flow against $16.6 million of capex, though trailing twelve-month free cash flow is only $63.1 million, implying a thin FCF yield of roughly 0.9% on the $6.98 billion market cap. The company returned capital via $58.7 million of dividends and $25.4 million of buybacks in Q1 2026 while repaying $180.3 million of debt, and with $474.3 million of cash it can fund growth internally, but the elevated 1.48x leverage and lumpy quarterly cash flow (Q3 2025 operating cash flow was -$182.5 million) warrant monitoring.
Quarterly Revenue
$660500000.0B
2026-03
Revenue YoY Growth
-3.5%
YoY Comparison
Gross Margin
30.6%
Latest Quarter
Free Cash Flow
$63100000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBP Overvalued?
Because IBP is profitable (Q1 2026 net income of $34.8 million; trailing EPS positive), the PE ratio is the appropriate primary metric. The stock trades at a trailing PE of 26.58x versus a forward PE of 18.48x, a roughly 30% compression that implies the market expects meaningful earnings recovery, consistent with consensus EPS estimates of $12.39 for the forward period versus the current trailing run-rate. On a price-to-sales basis, IBP trades at 2.35x, with an EV/Sales of 2.04x and EV/EBITDA of 14.45x, which are moderate for a profitable, cash-generative installer but rich relative to the company's own history. Peer comparison data is not explicitly provided in the valuation dataset, so a precise sector spread cannot be quantified; however, the 9.83x price-to-book and 3.99x PEG ratio suggest the market is paying a premium for a business whose earnings growth is currently negative, which is difficult to justify without a housing recovery. Historically, IBP's PE has ranged from roughly 8.8x (Q4 2022) to 51.0x (Q1 2026), and its PS ratio has ranged from about 3.2x (Q3 2022) to 10.8x (Q1 2026); the current 26.58x PE and 2.35x PS sit in the middle-to-upper portion of the historical band, well above the 2022-2023 trough multiples of 8-10x PE and 3-5x PS. This suggests the market is pricing in an optimistic earnings recovery rather than a deep cyclical trough, leaving limited valuation cushion if housing starts remain depressed.
PE
26.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin deleverage and cash flow lumpiness. Gross margin fell to 30.55% in Q1 2026 from 32.67% a year earlier and operating margin contracted to 8.87% from 10.19%, showing that fixed costs are not flexing fast enough as revenue declines 3.55% YoY. Debt-to-equity of 1.48x is elevated for a cyclical, and trailing twelve-month free cash flow of only $63.1 million implies a thin 0.9% FCF yield on the $6.98 billion market cap, while quarterly cash flow is lumpy (Q3 2025 operating cash flow was -$182.5 million). Revenue is also concentrated in the Installation segment ($609.8 million) and Insulation ($376.5 million), leaving IBP heavily exposed to single-family new construction volumes.
Market and competitive risks are dominated by housing cyclicality and valuation compression. With a beta of 1.72, IBP is roughly 72% more volatile than the market, so any macro shock or rate-driven housing slowdown is amplified in the share price. At 26.58x trailing PE, 2.35x PS, and 9.83x book, the stock trades in the upper-middle of its historical band versus 8-10x PE trough multiples in 2022-2023, meaning multiple compression alone could erase gains even if earnings hold. The QXO-TopBuild consolidation adds competitive uncertainty: a larger, better-capitalized rival could pressure pricing, though IBP is also framed as a relative safe haven. Analyst sentiment offers little support, with JP Morgan maintaining Underweight and the consensus at 'hold' (2.71 mean rating).
In a worst-case scenario, continued single-family housing weakness drives further volume declines, gross margins fall below 30%, and forward EPS estimates of $12.39 are cut, forcing the forward PE back toward the 8-10x trough range and the stock toward its 52-week low of $176.15 — about -11.5% from the current $199.12. A more severe outcome, aligned with the $160 analyst low target, implies roughly -20% downside, and the historical max drawdown of -47.61% shows how far the stock can fall in a full cyclical unwind. Investors should size positions well below a market-beta equivalent given the 1.72 beta and the falling-knife technical profile.
FAQ
The most severe risk is housing cyclicality: revenue fell 3.55% YoY in Q1 2026 and gross margin compressed to 30.55% from 32.67%, and with a beta of 1.72 any further decline in single-family starts would be amplified in both earnings and the share price. Second is valuation compression — at 26.58x trailing PE versus 8-10x trough multiples, a de-rating alone could erase significant value even if earnings hold. Third is financial/operational risk from 1.48x debt-to-equity and lumpy cash flow (Q3 2025 operating cash flow was -$182.5 million), with trailing FCF of just $63.1 million implying a thin 0.9% yield. Fourth is competitive risk from the QXO-TopBuild consolidation, which could create a larger, better-capitalized rival and pressure pricing. Ranked by severity: housing cyclicality first, valuation compression second, competitive dynamics third, and balance-sheet/cash-flow risk fourth.
The 12-month outlook has three scenarios. The base case (55% probability) targets $200-$225, assuming housing stabilizes at low levels, margins hold near 30-32%, and the stock trades around the $213.46 analyst average on forward EPS of $12.39. The bull case (20% probability) targets $257-$270, requiring a single-family housing recovery, gross margin back above 33%, and multiple expansion toward the analyst high target of $257. The bear case (25% probability) targets $160-$176, assuming a prolonged downturn, gross margin below 30%, and EPS estimate cuts driving the stock toward the $176.15 52-week low and the $160 analyst low target. The base case is most likely, with the key assumption being that single-family starts bottom without a further leg down and that cost actions keep gross margin above 30%.
IBP looks fairly valued to slightly expensive relative to its own history and its current negative growth. At 26.58x trailing PE, 2.35x PS, 9.83x book, and a 3.99x PEG ratio, the stock sits in the middle-to-upper portion of its historical band, well above the 2022-2023 trough multiples of roughly 8-10x PE. The forward PE of 18.48x is more reasonable, but that 30% compression from trailing levels means the market is already paying for a recovery to $12.39 in EPS. With revenue declining 3.55% YoY and gross margin compressing to 30.55%, the current multiple is difficult to justify without a housing inflection. The market appears to expect an earnings recovery and margin stabilization over the next year; if those fail to materialize, the stock would look overvalued and could de-rate toward trough multiples.
From a risk/reward perspective, IBP is a balanced-to-slightly-negative proposition at $199.12. The stock offers only about +7.2% upside to the $213.46 average analyst target against a 'hold' consensus (2.71 mean rating), while the bear case toward the $160 low target implies roughly -20% downside. The valuation is not distressed — 26.58x trailing PE and 2.35x PS sit in the upper-middle of the historical band — so the market is already pricing an earnings recovery via the 18.48x forward PE. The biggest downside risk is a prolonged housing downturn that cuts forward EPS of $12.39 and compresses the multiple. It could be a good buy for patient, value-oriented investors with a multi-year horizon who want housing-recovery exposure and can tolerate a 1.72 beta, particularly on a pullback toward the $176.15 52-week low or on confirmation that single-family starts are inflecting.
IBP is better suited to a long-term holding period of at least 18-24 months rather than short-term trading. The stock is a cyclical housing-recovery play with a 1.72 beta and a -47.61% historical max drawdown, so short-term price action is dominated by housing data and rate expectations rather than company fundamentals. Earnings visibility is limited — revenue is declining 3.55% YoY and analyst targets span a wide $160-$257 range — which makes near-term trading highly speculative. The dividend yield of 1.26% with a 33% payout ratio provides modest income but is not a reason to own the stock. A patient investor with a multi-year horizon can wait for the housing cycle to turn, at which point the 18.48x forward PE on recovering earnings could deliver meaningful total return; short-term traders should respect the downtrend and the $176.15 support level.